Access to the care patients need is now easier than ever, with a new collaboration between CarepathRx and University of Pittsburgh Medical Center’s (UPMC) Chartwell subsidiary. BioPlus Specialty Pharmacy, as a part of the CarepathRx family, looks forward to serving an essential role in what will truly be a first-of-its-kind pharmacy solution for hospitals and health systems. The CarepathRx and Chartwell collaboration will create an end-to-end hospital pharmacy solution that not only increases quality of care and improves patient outcomes but also optimizes hospital financial results.
BioPlus Specialty Pharmacy earned a coveted spot on the Orlando Sentinel’s 2020 Top Workplaces as announced in a virtual awards ceremony, as well as in a special edition of the Orlando Sentinel on November 15, 2020.
The prostate cancer medication Xtandi® is now available through BioPlus Specialty Pharmacy. Xtandi has been approved by the FDA to treat three . . .
As the COVID-19 pandemic continues its assault on the globe and the U.S. passes 12,000 deaths from it, all eyes are on the health care industry. While the public looks to pharma manufacturers for potential …
Patients and even health care providers are probably feeling a lot of uncertainty and anxiety right now. You can count on BioPlus to continue to do our best and keep you informed throughout this COVID-19 pandemic. In fact, when it comes to their . . .
The prostate cancer medication Xtandi® is now available through BioPlus Specialty Pharmacy. Xtandi has been approved by the FDA to treat three . . .
